Alain Schotte

3.7k total citations · 1 hit paper
39 papers, 3.1k citations indexed

About

Alain Schotte is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Alain Schotte has authored 39 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 9 papers in Psychiatry and Mental health. Recurrent topics in Alain Schotte's work include Receptor Mechanisms and Signaling (23 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuropeptides and Animal Physiology (12 papers). Alain Schotte is often cited by papers focused on Receptor Mechanisms and Signaling (23 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuropeptides and Animal Physiology (12 papers). Alain Schotte collaborates with scholars based in Belgium, United States and Netherlands. Alain Schotte's co-authors include J.E. Leysen, Pierre M. Laduron, Walter Luyten, W Gommeren, Paul Van Gompel, Anne Lesage, Anton A. H. P. Megens, Paul Janssen, J E Leysen and P.F.M. Janssen and has published in prestigious journals such as Biological Psychiatry, Brain Research and FEBS Letters.

In The Last Decade

Alain Schotte

38 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 971 citations Alain Schotte, Paul Janssen et al. Psychopharmacology profile →

Peers

Countries citing papers authored by Alain Schotte

Since Specialization

Citations

This map shows the geographic impact of Alain Schotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Schotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Schotte more than expected).

Fields of papers citing papers by Alain Schotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Schotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Schotte. The network helps show where Alain Schotte may publish in the future.

Co-authorship network of co-authors of Alain Schotte

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Schotte. A scholar is included among the top collaborators of Alain Schotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Schotte. Alain Schotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study 2016 ·The International Journal of Neuropsychopharmacology ·Adam Savitz, Haiyan Xu, Srihari Gopal, Isaac Nuamah, Paulien Ravenstijn, Adam Janik, Alain Schotte, David Hough, Wolfgang Fleischhacker	128
2	Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response 2006 ·Psychiatry Research Neuroimaging ·Ana M. Catafau, Iluminada Corripio, Víctor Pérez, Martín Jc, Alain Schotte, Ignasi Carrió, Enric Álvarez	13
3	Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat 1998 ·Synapse ·M. Janneke Mijnster, Alain Schotte, (unknown), Pieter Voorn	9
4	Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine 1997 ·Synapse ·Patrizia Nestby, Alain Schotte, Paul F.M. Janssen, Guno H.K. Tjon, Louk J. M. J. Vanderschuren, Taco J. De Vries, Arie H. Mulder, J.E. Leysen, Anton N. M. Schoffelmeer	14
5	Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function 1997 ·Neuroscience ·Pascal Bonaventure, Pieter Voorn, Walter Luyten, Mirek Jurzak, Alain Schotte, J.E. Leysen	100
6	Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study 1996 ·The Histochemical Journal ·Alain Schotte, P.F.M. Janssen, Pascal Bonaventure, J.E. Leysen	38
7	Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding breakdown → 1996 ·Psychopharmacology ·Alain Schotte, Paul Janssen, W Gommeren, Walter Luyten, Paul Van Gompel, Anne Lesage, (unknown), J.E. Leysen	971
8	Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. 1996 ·Molecular Pharmacology ·J.E. Leysen, W Gommeren, Lieve Heylen, Walter Luyten, Inez Van de Weyer, Piet Vanhoenacker, Guy Haegeman, Alain Schotte, Paul Van Gompel, Ria Wouters, Anne Lesage	78
9	In Vitro Receptor Binding and In Vivo Receptor Occupancy in Rat and Guinea Pig Brain: Risperidone Compared with Antipsychotics Hitherto Used 1995 ·The Japanese Journal of Pharmacology ·Alain Schotte, Pascal Bonaventure, Paul F.M. Janssen, Josée E. Leysen	74
10	Evidence For Two Neurochemical Divisions in the Human Nucleus Accumbens 1994 ·European Journal of Neuroscience ·Pieter Voorn, Linda S. Brady, Alain Schotte, Henk W. Berendse, Eric K. Richfield	56
11	Survey on the pharmacodynamics of the new antipsychotic risperidone 1994 ·Psychopharmacology ·Anton A. H. P. Megens, F. Awouters, Alain Schotte, T. Meert, Christine Dugovic, C. J. E. Niemegeers, J.E. Leysen	175
12	Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors 1993 ·Psychopharmacology ·J E Leysen, (unknown), Alain Schotte, (unknown), Anton A. H. P. Megens	281
13	Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography 1993 ·Brain Research ·Alain Schotte, P.F.M. Janssen, Anton A. H. P. Megens, J.E. Leysen	190
14	Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo 1992 ·European Journal of Pharmacology ·Alain Schotte, Paul F.M. Janssen, W Gommeren, (unknown), Josée E. Leysen	46
15	6.2 Role and localization of serotonin-5HT2 receptors 1992 ·Progress in Histochemistry and Cytochemistry ·J.E. Leysen, Alain Schotte	5
16	Identification of 5-HT2 receptors, α1-adrenoceptors and amine release sites in rat brain by autoradiography with [125I]7-amino-8-iodo-ketanserin 1989 ·European Journal of Pharmacology Molecular Pharmacology ·Alain Schotte, J E Leysen	20
17	Further characterization of neurotensin binding in the rat brain: levocabastine-displaceable neurotensin binding sites are not histamine-H1 receptors 1989 ·Biochemical Pharmacology ·Alain Schotte, Josée E. Leysen	12
18	Different Subcellular Localization of Neurotensin‐Receptor and Neurotensin‐Acceptor Sites in the Rat Brain Dopaminergic System 1988 ·Journal of Neurochemistry ·Alain Schotte, William Rostène, Pierre M. Laduron	62
19	Distinct autoradiographic labelling of serotonin 5-HT2 receptors, α1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin 1988 ·European Journal of Pharmacology ·Alain Schotte, Josée E. Leysen	23
20	Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution 1987 ·European Journal of Pharmacology ·Patrick Kitabgi, William Rostène, Monique Dussaillant, Alain Schotte, Pierre M. Laduron, Jean‐Pierre Vincent	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact